$0.00390
At close: Mar 31, 3:39 PM EDT
Comments
Loading...
MediXall Group Analyst Ratings and Price Targets | OTC:MDXL | Benzinga
MediXall Group Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for MediXall Group Corp from these most-recent analyst ratings.
Analyst Ratings for MediXall Group
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for MediXall Group (MDXL) stock?
There is no price target for MediXall Group
What is the most recent analyst rating for MediXall Group (MDXL)?
There is no analyst for MediXall Group
When was the last upgrade for MediXall Group (MDXL)?
There is no last upgrade for MediXall Group
When was the last downgrade for MediXall Group (MDXL)?
There is no last downgrade for MediXall Group.
When is the next analyst rating going to be posted or updated for MediXall Group (MDXL)?
There is no next analyst rating for MediXall Group.
Is the Analyst Rating MediXall Group (MDXL) correct?
There is no next analyst rating for MediXall Group.
Browse analyst ratings and price targets on all stocks.
